Entral Feeding in Acute Severe Pancreatitis

Status Completed

Clinical Trial Summary

• A total of 60 patients admitted to King Abdulaziz Specialists Hospital between June 2018 and April 2020 with both a clinical and biochemical presentation of acute pancreatitis with the following inclusion criteria: Abdominal pain > 6 on the visual analogue scale without given analgesia , abdominal distension and tenderness with serum amylase and serum lipase at least 3 times the upper limit of the reference range (considering normal lipase level from 0-160 U/L, and normal amylase level from 0-100 U/L) with confirmed abdominal computerized axial tomography of grade D and E on Ranson and colleagues criteria(28) of inflamed pancreatic picture.

Clinical Trial Description

- The study was conducted on monitoring of four pillar for 13 days (data collected one day before feeding and every three days for 12 days). the first pillar comparing the effect of the two enteral feeding methods on the clinical condition of the acute severe pancreatitis and this monitored clinically and laboratory by fixed parameters, clinically, by abdominal pain which assessed by visual analogue scale (VAS). and laboratory, by both markers of severity of pancreatic acini destruction which assessed by serum amylase, lipase and Markers of severity of interstitial pancreatic tissue destruction which assessed by the level of Lactate Dehydrogenase level (LDH), Aspartate aminotransferase (AST), C-reactive protein, prostacyclin and interleukin 8. The second pillar include effect of the two enteral feeding methods on the patient's tolerance and these monitored in our study by both post-feeding vomiting and post feeding attacks of osmotic diarrhea and also abdominal pain. Third pillar include effect of the two enteral feeding methods on the patient's general condition and these monitored by follows the APACHE II Score, hemodynamics of the patients in both groups (Mean arterial blood pressure and pulse) and arterial oxygen saturation (Spo2). Fourth pillar include effect of the two enteral feeding methods on achieving satisfactory nutrition parameters of the patients and both albumin level, radium blood sugar and electrolytes (sodium and potassium level) used as indicator for this.

- All parameters observed one day before starting feeding and every 3 days for 12 days (duration of the study). ;

Study Design

Related Conditions & MeSH terms

Pancreatitis
Postoperative Nausea
Postoperative Nausea and Vomiting

Clinical Trial Details

NCT number	NCT04406506
Study type	Observational [Patient Registry]
Source	King Abdul Aziz Specialist Hospital
Contact
Status	Completed
Phase
Start date	June 10, 2018
Completion date	April 10, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03639012` - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy	N/A
Not yet recruiting	`NCT01389570` - Postoperative Nausea/Vomiting and Acupressure	Phase 2
Completed	`NCT00830089` - Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery	N/A
Terminated	`NCT05112575` - Evaluation of Patient Stress Level Caused by Radiological Investigations in Early Postoperative Phase After Craniotomy
Completed	`NCT04759079` - The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy	N/A
Active, not recruiting	`NCT03712891` - Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU	N/A
Completed	`NCT01834898` - Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery	N/A
Completed	`NCT03631004` - Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients	Phase 2/Phase 3
Completed	`NCT05618236` - Sugammadex and Neostigmine in Pediatric Patients
Not yet recruiting	`NCT05632224` - Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery	Phase 4
Completed	`NCT01020903` - Aprepitant for Post-operative Nausea	N/A
Completed	`NCT00793663` - Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia	Phase 4
Completed	`NCT03503292` - Pharmacogenomics and Post-Operative Nausea and Vomiting	Phase 4
Completed	`NCT05841693` - Quality of Recovery in Parturients Consumed Preoperative Carbohydrate Fluid for Elective Cesarean Delivery	Phase 4
Completed	`NCT04742660` - The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting	N/A
Completed	`NCT03100669` - Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program Via Tele-monitoring
Terminated	`NCT02765750` - Postoperative Outcomes After Positive Intraoperative Messages	N/A
Terminated	`NCT01798316` - IV Acetaminophen for Postoperative Analgesia	Phase 4
Completed	`NCT03387956` - Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting	N/A
Completed	`NCT04718727` - Olanzapine for the Prevention of Postoperative Nausea and Vomiting	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.